Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28788 |
SK-216
SK216.Plasminogen activator inhibitor-1 (PAI-1) inhibitor |
||
SK-216 is a specific PAI-1 inhibitor. SK-216 reduced the extent of angiogenesis in the tumors and inhibited VEGF-induced migration and tube formation by human umbilical vein endothelial cells in vitro. SK-216 reduced the degree of bleomycin-induced pulmon | |||
T24106 |
GSK2163632A
GSK-2163632-A,GSK 2163632 A |
||
GSK2163632A is an insulin-like growth factor 1 receptor inhibitor that acts by binding to a novel region of the GRK active site cleft. |